Emergent BioSolutions to Participate in Investor Conferences

GAITHERSBURG, Md., March 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences:

KeyBanc Life Sciences & MedTech Investor Forum

Company fireside chat scheduled for 1:30 pm eastern

BofA Securities 2022 Healthcare Conference

Presentation scheduled for 12:00 pm eastern

Goldman Sachs 7th Annual Leveraged Finance and Credit Conference

Presentation date and time will be updated on the Emergent website as the information becomes available.

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutions

Vice President, Investor Relations

Senior Director, Media Relations

Emergent Investor Conferences

Investor Conferences